FILGOTINIB, A SELECTIVE JAK1 INHIBITOR, INDUCES CLINICAL REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE CROHN?S DISEASE: FINAL ANALYSIS OF THE PHASE 2 FITZROY STUDY

Severine Vermeire  1     Stefan Schreiber  2     R. Petryka  3     Tanja Kuehbacher  4     Xavier Hebuterne  5     Xavier Roblin     Maria Klopocka     Eugen-Adrian Goldis     Maria Wisniewska Jarosinska     Andrey Baranovsky     Robert Sike     Kremana Stoyanova     Chantal Tasset     Annegret Van der Aa     Pille Harrison    
1 University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium
2 Universit├Ąt Kiel UKSH Medizinische Abt. I, UKSH, Kiel, Germany
3 Gastroenterol., NZOZ Vivamed, Warszawa, Poland, Warsaw, Poland
4 Asklepios Wet Hospital Clinic of Internal Medicine, Dept of gastroenterology, Hamburg, Germany
5 Hospital Arche 2, Hepatogastroenter

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing